Davidson H, Schluger N W, Feldman P H, Valentine D P, Telzak E E, Laufer F N
Department of Health Care Quality, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA.
Int J Tuberc Lung Dis. 2000 Sep;4(9):860-5.
Six New York State Department of Health tuberculosis (TB) directly observed therapy (DOT) programs in public, private and community facilities in New York City.
A key feature of the TB DOT program was provision of incentives to motivate patients and increase adherence to therapy. The study hypothesis was that adherence will improve as the value of incentives increases and bonuses are added in a schedule of increasing rewards.
The study population consisted of 365 patients in six inner city TB DOT programs. Interviews, clinical data and attendance records for 3+ years were analyzed.
Patients who adhered (attending 80% of prescribed DOT visits each month of treatment) and those who did not were similar on seven demographic factors (e.g., age and sex), but were significantly different on clinical and social variables. Previous TB, resistance to rifampin, human immunodeficiency virus infection, psychiatric illness, homelessness, smoking and drug use were related to non-adherence. High adherence was significantly associated with fewer months in treatment (P < 0.016). Logistic regression showed that the odds that a patient would adhere to therapy were greater with increased incentives. Odds of adherence were significantly lower with rifampin resistance and psychiatric illness.
Increasing incentives is associated with improved adherence to therapy in inner city TB populations.
纽约市6个由纽约州卫生部开展的结核病(TB)直接督导下的治疗(DOT)项目,分布于公共、私人及社区医疗机构。
结核病DOT项目的一个关键特征是提供激励措施以促使患者并提高治疗依从性。研究假设是随着激励措施价值的增加以及在递增奖励计划中增加奖金,依从性将会提高。
研究对象包括6个市中心结核病DOT项目中的365名患者。对3年多的访谈、临床数据及出勤记录进行了分析。
坚持治疗(在治疗的每个月中参加80%规定的DOT访视)和未坚持治疗的患者在7个人口统计学因素(如年龄和性别)上相似,但在临床和社会变量上存在显著差异。既往患结核病、对利福平耐药、感染人类免疫缺陷病毒、患有精神疾病、无家可归、吸烟及吸毒与治疗依从性差有关。高依从性与治疗时间较短显著相关(P < 0.016)。逻辑回归分析显示,随着激励措施的增加,患者坚持治疗的几率更高。对利福平耐药和患有精神疾病的患者坚持治疗的几率显著较低。
增加激励措施与市中心结核病患者治疗依从性的提高有关。